L-lysinate is a salt of lysine, an amino acid humans cannot make, found in mineral supplements and some pain relievers, of interest for cold sores, stress and calcium uptake. Cold-sore prevention remains contested; stress, calcium and blood-sugar signals rest on small, often indirect studies. Up to about six grams daily appears well tolerated; kidney health is the main open safety question; for health-focused adults, expected gains are modest and uncertain.
(Full Review)
Risk & Side Effects
- High: Kidney strain with drug lysinates
- Medium: Stomach and gut injury with drug lysinates; other adverse events in premature infants with ibuprofen lysinate
- Low: Gastrointestinal upset; kidney tubule injury; heart and vascular events with ibuprofen lysinate; bleeding with drug lysinates; asthma and allergic reactions with aspirin lysinate; serious skin and hypersensitivity reactions with ibuprofen lysinate; liver injury with aspirin lysinate; gout attacks with aspirin lysinate; pulmonary hypertension in premature infants with ibuprofen lysinate; infection masking and sepsis in premature infants with ibuprofen lysinate; hemolysis in G6PD deficiency with aspirin lysinate; tinnitus and hearing loss with high-dose aspirin lysinate; blood-cell disorders with aspirin lysinate; Reye's syndrome in children and adolescents with aspirin lysinate; fetal harm in late pregnancy with drug lysinates; high blood potassium with infused lysine and arginine; other label-listed reactions with aspirin lysinate
- Speculative: Reduced arginine availability and nitric oxide; concerns in cardiovascular and gallbladder disease; bilirubin displacement in premature infants with ibuprofen lysinate
Monitoring
| Marker |
Target |
Why |
|
Serum creatinine
|
About 0.6–1.2 mg/dL, lab-specific
|
Safety check: a rise stops use
|
|
Urinalysis (glucose, protein)
|
Negative for glucose and protein
|
Safety check: new glucose or protein stops use
|
|
Serum calcium
|
8.5–10.2 mg/dL
|
Safety check with calcium lysinate or added calcium
|
|
HbA1c
|
4.0–5.6%
|
Expected to change if blood-sugar effects occur
|
|
Estimated glomerular filtration rate (eGFR)
|
Not specified in the ER
|
Kidney filtering capacity, paired with creatinine
|
|
Serum albumin
|
Not specified in the ER
|
Paired with serum calcium
|
|
Fasting glucose
|
Not specified in the ER
|
Paired with HbA1c
|
Cadence:
Baseline before gram-level intake; kidney tests and urinalysis at 3 months, then every 6–12 months; serum calcium at 3 months with calcium lysinate; HbA1c after 3 months. These cadences follow common practice rather than trial protocols. Drug lysinates follow the parent drug's monitoring.
Qualitative Assessment
-
Cold-sore frequency, duration and severity, tracked in a diary against the prior year
-
Perceived stress and anxiety, rated weekly
-
Gastrointestinal comfort (nausea, bloating, stool changes)
-
Energy and fluid balance (unusual thirst or urination can signal tubule problems)